Welcome Video from the Editors of NEJM Evidence
124
0
2024-3-22 16:50
Drug-Eluting Scaffold for Infrapopliteal Disease
2023 Notable Articles | New England Journal of Medicine
Daratumumab Plus VRd for Multiple Myeloma
Resmetirom for NASH with Liver Fibrosis
The Plight of Primary Care, Part 2
Understanding Heparin-Induced Thrombocytopenia (HIT)：Causes, pathophysiology, and Treatment
The Plight of Primary Care, Part 1
Type 2 Diabetes — Controlling the Epidemic (Episode 2 of 4) | NEJM
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
NEJM Evidence, a new monthly digital journal from NEJM Group, presents innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making. Learn what type of content you can expect from the editors of NEJM Evidence.
Comments 0
Please to post a comment~
Loading...
Related Suggestion